Antimicrobial Strategies for Multidrug-Resistant Acinetobacter Infections
Summary
Multidrug-resistant Acinetobacter, notably carbapenem-resistant A. baumannii, represents a mounting global health threat due to its capacity for rapid acquisition of resistance determinants and its association with severe nosocomial infections. Contemporary strategies focus on optimising existing antibiotics through dose adjustment and combination regimens, alongside the development of novel agents targeting unique bacterial structures. Advances include therapies that inhibit lipopolysaccharide transport, refined use of β-lactamase inhibitors, and exploration of adjunct approaches such as bacteriophage therapy and antimicrobial peptides. A deeper understanding of resistance mechanisms and pharmacokinetic-pharmacodynamic relationships underpins efforts to personalise treatment, reduce toxicity and improve outcomes in critically ill patients.
Research from Nature Portfolio
Recent studies have identified and optimised a tethered macrocyclic peptide antibiotic that selectively blocks the LptB2FGC lipopolysaccharide transporter, demonstrating potent in vitro activity and effective clearance of highly resistant A. baumannii isolates in animal infection models. This work establishes the transporter as a tractable drug target and introduces a first-in-class compound with therapeutic potential against strains impervious to current treatments. Building on this, a comprehensive meta-analysis of colistin therapy has shown that pairing colistin with complementary agents enhances microbiological eradication rates without a significant rise in nephrotoxicity, refining the clinical role of polymyxin-based combinations.
Antimicrobial Strategies for Multidrug-Resistant Acinetobacter Infections publication trend
The graph below shows the total number of articles in antimicrobial strategies for multidrug-resistant acinetobacter infections across all publications each year (not limited to Nature Index journals).
Technical terms
Carbapenem-resistant Acinetobacter baumannii (CRAB): A strain of A. baumannii resistant to carbapenem antibiotics.
Macrocyclic peptide antibiotics: Synthetic cyclic peptides designed to target essential bacterial processes.
LptB2FGC complex: Protein assembly responsible for transporting lipopolysaccharide to the bacterial outer membrane.
β-lactamase inhibitor: Compound that blocks bacterial enzymes which degrade β-lactam antibiotics.
Pharmacokinetic-pharmacodynamic principles: The study of how drug concentration and timing relate to antimicrobial effect.
Bacteriophage therapy: Use of viruses specific to bacteria as antibacterial agents.
Antimicrobial peptides: Short amino-acid sequences that disrupt microbial cell membranes.
References
- A novel antibiotic class targeting the lipopolysaccharide transporter. Nature (2024).
- Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection. Scientific Reports (2015).
- Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections. Clinical Infectious Diseases (2023).
- Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review. Antimicrobial Resistance & Infection Control (2019).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.